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oxoplasma gondii
 
 replicates within a specialized vac-
uole surrounded by the parasitophorous vacuole
membrane (PVM). The PVM forms intimate interac-
tions with host mitochondria and endoplasmic reticulum
(ER) in a process termed PVM–organelle association. In this
study we identify a likely mediator of this process, the para-
site protein ROP2. ROP2, which is localized to the PVM, is
secreted from anterior organelles termed rhoptries during
parasite invasion into host cells. The NH
 
2
 
-terminal domain
of ROP2 (ROP2hc) within the PVM is exposed to the host
cell cytosol, and has characteristics of a mitochondrial tar-
geting signal. In in vitro assays, ROP2hc is partially translo-
cated into the mitochondrial outer membrane and behaves
T
 
like an integral membrane protein. Although ROP2hc does
not translocate across the ER membrane, it does exhibit car-
bonate-resistant binding to this organelle. In vivo, ROP2hc
expressed as a soluble fragment in the cytosol of uninfected
cells associates with both mitochondria and ER. The 30–
amino acid (aa) NH
 
2
 
-terminal sequence of ROP2hc, when
fused to green ﬂuorescent protein (GFP), is sufﬁcient for mi-
tochondrial targeting. Deletion of the 30-aa NH
 
2
 
-terminal
signal from ROP2hc results in robust localization of the
truncated protein to the ER. These results demonstrate a
new mechanism for tight association of different mem-
brane-bound organelles within the cell cytoplasm.
 
Introduction
 
The protozoan parasite 
 
Toxoplasma gondii
 
 invades and repli-
cates within nucleated cells of warm-blooded animals (Dubey
and Beattie, 1988). Upon invasion, the parasite establishes it-
self within a specialized compartment, the parasitophorous
vacuole (PV)* (Mordue and Sibley, 1997; Mordue et al.,
1999b), which is circumscribed by the PV membrane
(PVM) (Lingelbach and Joiner, 1998). The PVM is a highly
specialized membrane that lacks integral membrane proteins
of host cell origin (Porchet-Hennere and Torpier, 1983;
Mordue et al., 1999a), but is extensively modified by se-
creted parasite proteins (Sinai and Joiner, 1997; Lingelbach
and Joiner, 1998).
The 
 
T. gondii
 
 PVM exhibits a remarkable association with
host mitochondria and ER (DeMelo et al., 1992; Sinai et al.,
1997) (see Fig. 1 A). We have previously termed this phe-
nomenon PVM–organelle association (Sinai et al., 1997).
Association of host organelles with the vacuolar membranes
surrounding intracellular pathogens is a feature restricted to
organisms that either never enter the endocytic cascade, or that
exit it soon after entry (Sinai and Joiner, 1997). Both 
 
Le-
gionella pneumophila
 
 (Swanson and Isberg, 1995) and 
 
Brucella
abortus
 
 (Pizarro-Cerda et al., 1998) replicate in a compart-
ment associated with the ER. In 
 
L. pneumophila–
 
infected cells,
a bacterially encoded machinery with homology to bacterial
DNA conjugation systems is required for establishment and
maintenance of the ER-associated replicative phagosome (Pur-
cell and Shuman, 1998; Vogel et al., 1998). However, the sub-
strates potentially being exported by this machinery remain
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elusive (Purcell and Shuman, 1998; Vogel et al., 1998). Even
less well understood is the molecular basis for mitochondrial
association observed with the inclusion (vacuole) membrane
housing certain strains of 
 
Chlamydia psittaci 
 
(Matsumoto et
al., 1991; Sinai and Joiner, 1997). Although host cytoplasm–
exposed proteins of chlamydial origin have been identified
in the inclusion membrane, no link to mitochondrial associ-
ation has been made (Rockey et al., 1997; Bannantine et al.,
1998). What is clear is that both mitochondrial association
by 
 
C. psittaci 
 
(Matsumoto et al., 1991) and ER association
by 
 
L. pneumophila
 
 (Swanson and Isberg, 1995) and 
 
B. abor-
tus
 
 (Pizarro-Cerda et al., 1998) are important in the establish-
ment of the replication-permissive compartment, and likely
involved in nutrient acquisition (Sinai and Joiner, 1997).
As the only barrier between the parasite and the nutrient-
rich cytoplasm, the PVM plays an integral role in nutrient
acquisition (Sinai and Joiner, 1997). In addition to a pore
permitting the free bidirectional transport of soluble mole-
cules 
 
 
 
1,300 D (Schwab et al., 1994), the PVM likely plays
a critical role in scavenging host cholesterol from the low
density lipoprotein pathway (Coppens et al., 2000). We
have postulated that PVM–organelle association exhibited
by 
 
T. gondii
 
 may serve as a mechanism to scavenge lipids
and/or lipid precursors from the infected host cell (Sinai and
Joiner, 1997; Sinai et al., 1997).
Proteins modifying the 
 
T. gondii
 
 PVM originate in the ex-
cretory/secretory organelles of the parasite (Sinai and Joiner,
1997; Lingelbach and Joiner, 1998). These include club-
shaped organelles called rhoptries (Dubremetz et al., 1998)
(see Fig. 1 A), discharged concomitant with parasite invasion
(Dubremetz et al., 1993; Carruthers and Sibley, 1997), and
dense granules (see Fig. 1 A) that release their cargo
throughout the intracellular residence of the parasite (Carru-
thers and Sibley, 1997). Morphometric data indicate that
PVM–organelle association is established early in infection
and does not increase with the time of intracellular resi-
dence, suggesting rhoptry involvement (Sinai et al., 1997).
PVM–organelle association is poorly understood at the mo-
lecular and biochemical levels (Sinai and Joiner, 1997). The
quest for the molecular basis of PVM–organelle association
is further confounded by the fact that the physical nature of
the interaction (i.e., Is it a protein–protein, protein–lipid,
lipid–lipid, or other interaction?) is not known.
In this study, we describe the molecular mechanism by
which the association between the 
 
T. gondii
 
 PVM and host
cell organelles is established. The general mechanism re-
ported here is one in which a PVM-anchored protein tethers
host organelle membranes by inserting into them, promoting
a stable association. This insight opens the way to defining
the role of PVM–organelle association in parasite biology,
and presents a mechanism by which organelle systems such as
mitochondria and ER may interact in eukaryotes in general.
 
Results
 
Host mitochondria associate with the PVM 
immediately after invasion
 
PVM–organelle association is likely mediated by PVM pro-
teins of parasite origin that are exposed to the host cyto-
 
plasm (Sinai et al., 1997). Several proteins derived from
both rhoptries and dense granules (Fig. 1 A) are known to
satisfy these criteria (Lingelbach and Joiner, 1998). These
include the rhoptry proteins of the ROP2 family (Beckers et
al., 1994) and the dense granule proteins GRA5 (Lecordier
et al., 1999), GRA7 (Fischer et al., 1998; Jacobs et al.,
1998), and GRA8 (Carey et al., 2000).
The kinetics for the establishment of PVM–mitochon-
drial association, examined immediately after parasite inva-
sion, were used to discriminate between the involvement of
a rhoptry- or dense granule–derived factor. Within 1 min of
infection, 36% of intracellular 
 
T. gondii
 
 vacuoles had at least
one mitochondrial profile associated with the PVM (Fig. 1
B, arrowheads). Notably, all of the staining for the PVM-
localizing, dense granule marker GRA3 (Bermudes et al.,
1994) was still retained within the parasite (Fig 1 B). The
extent of PVM–mitochondrial association increased to 68
and 74% of vacuoles at 5 and 10 min postinfection, respec-
tively (Fig. 1 B). By these time points, dense granule exocy-
tosis is apparent (Carruthers and Sibley, 1997), resulting in
GRA3 release into the vacuolar space and the PVM (Fig. 1
B). Therefore, the kinetics of PVM–mitochondrial associa-
tion correlate better with rhoptry than with dense granule
exocytosis (Fig. 1 B), as previously suggested (Sinai et al.,
1997). This finding prompted us to examine ROP2, the
founding member of a family of proteins known to be in the
PVM (Beckers et al., 1994), as a potential mediator of
PVM–mitochondrial association.
 
The NH
 
2
 
-terminal domain of mature ROP2
is exposed to the host cell cytoplasm
 
In the infected cell, members of the ROP2 family are pre-
dominant antigens of the PVM where they are exposed to
the host cell cytoplasm (Beckers et al., 1994). This earlier
observation was in part based on labeling of the PVM with
an antiserum against the rhoptry/dense granule (R/DG)
fraction of the parasite, after selective permeabilization of in-
fected host cells (Beckers et al., 1994). We sought to identify
the domain within ROP2 containing the epitope(s) recog-
nized by the R/DG antiserum.
The ROP2 protein is processed within the secretory path-
way of the parasite en route to the rhoptry (Fig. 2 A) (Sadak
et al., 1988; Leriche and Dubremetz, 1991). Although the
precise processing site is unclear, NH
 
2
 
-terminal sequencing
of an ROP2 fragment indicates that aa 98 is at or close to
the processing site (Dubremetz, J.-F., personal communica-
tion) (Fig. 2 A). Therefore, we divided ROP2 into an NH
 
2
 
-
terminal domain (aa 98–465) and a COOH-terminal do-
main (aa 466–561) around its predicted transmembrane
region (Fig. 2 A). These domains were synthesized in vitro as
 
35
 
S-Met–labeled substrates, and the ability of the R/DG an-
tiserum to immunoprecipitate them was determined. The
R/DG antiserum selectively immunoprecipitated the NH
 
2
 
-
terminal domain of mature ROP2 (aa 98–465; Fig. 2 B),
but not a chimera of bacterial alkaline phosphatase (BAP)
with the ROP2 transmembrane domain and COOH termi-
nus (aa 466–561) (Fig. 2 B). This observation indicates that
the NH
 
2
 
-terminal domain of PVM-localized ROP2 is ex-
posed to the host cytoplasm (RO2hc; aa 98–465). 
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ROP2hc contains a potential mitochondrial import signal 
and is partially translocated into murine mitochondria
 
Examination of the ROP2 protein sequence (Beckers et al.,
1994) immediately downstream of aa 98 revealed features
reminiscent of a mitochondrial matrix targeting signal (Fig.
3 A); these include a predicted positively charged amphi-
pathic helix (Fig. 3 A, underlined), a high concentration of
hydroxylated residues (Fig. 3 A, asterisk), and a relative lack
of negatively charged aa (von Heijne, 1990; Neupert, 1997).
We tested the possibility that mature ROP2, when localized
to the PVM, interacts with the host mitochondrial import ma-
chinery. Upon incubation with freshly isolated murine mito-
chondria, ROP2hc associated with the pellet fraction (Fig. 3
B, lane 2). To determine if the interaction with the mitochon-
drial pellet was the result of translocation into the mitochon-
drion, the resistance of ROP2hc to exogenous protease was
assessed. Upon the addition of trypsin, a specific 17-kD
fragment was revealed in the pellet fraction (Fig. 3 B, lane 4,
Figure 1. Mitochondrial association with the T. gondii PVM occurs 
at the time of invasion. (A) Ultrastructural features of a T. gondii para-
sitophorous vacuole 20 h after infection of CHO cells, containing four 
parasites (P) within the vacuole. The major secretory organelles in-
cluding rhoptries (R), dense granules (DG), and micronemes (m) are 
indicated. The PV is delimited from the host cell by the PVM, which 
associates intimately with host mitochondria (M) and ER. (B) Host mi-
tochondria associate with the PVM immediately after infection. PVs 
containing intracellular T. gondii, with associated mitochondria (ar-
rowheads), were identified on the basis of their phase contrast charac-
teristics (C, F, and I) and the distribution of the dense granule and 
PVM marker GRA3 (A, D, and G). Host mitochondria were identified 
using the specific dye MitoTracker (B, E, and H). Host mitochondria 
associated with the PVM follow the contour of the vacuole (arrow-
head). Parasite infection was stopped at 1 (A–C), 5 (D–F), and 10 (G–I) 
min postinfection, and the extent of release of the dense granule marker 
GRA3 determined by immunofluorescence (A, D, and G). GRA3 label-
ing is confined to dense granules and is not detected in either the PV or 
PVM 1 min postinfection (A). At 5 min postinfection, patchy PVM stain-
ing (D, arrowhead) is detected in most vacuoles, which becomes cir-
cumferential by 10 min postinfection (G, arrowheads), indicating dense 
granule exocytosis. In contrast, MitoTracker-labeled PVM-associated 
mitochondria are readily apparent, surrounding the vacuole at all time 
points (B, E, and G, arrowhead). Detection of PVM-associated mito-
chondria (B) before dense granule exocytosis (A) indicates dense gran-
ule products are not required. Bars, 5  m.
Figure 2. Determination of the topology of ROP2 in the PVM. (A) 
The processing of ROP2 in T. gondii. The gene encoding ROP2 pre-
dicts a 64-kD protein including an NH2-terminal signal sequence 
(SS) (Beckers et al., 1994). Signal sequence cleavage in the parasite 
ER is followed by an additional processing event (Sadak et al., 1988; 
Leriche and Dubremetz, 1991). Cleavage at aa 98 predicts a 53.5-
kD protein, somewhat smaller than the observed 55 kD for the ma-
ture protein (Leriche and Dubremetz, 1991; Sadak et al., 1988), 
while cleavage at aa 80 would predict a 57.5-kD protein. The pro-
tein can be divided into the NH2-terminal domain (aa 98–465) and 
the transmembrane domain and COOH-terminus (aa 46–561). A 
chimera of BAP and the COOH-terminal domain of ROP2hc (aa 
466–561) was constructed (BAP-ROP2TM/CT). (B) Immunoprecipi-
tation of 
35S-Met–labeled in vitro–synthesized NH2-terminal domain 
(aa 98–465) and BAP-ROP2TM/CT with an antiserum against the 
R/DG fraction of the parasite. R/DG immunoprecipitates the NH2-
terminal domain but not BAP-ROP2TM/CT, indicating that the NH2-
terminal domain of ROP2 is exposed to the host cytoplasm. 
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arrowhead). This fragment is not observed in the supernatant
fraction (Fig. 3 B, lane 5), or when protease treatment is per-
formed in the presence of either Triton X-100 (Fig. 3 B, lane
6) or SDS (unpublished data). The conversion of ROP2hc
from protease resistance (Fig. 3 B, lane 4, arrowhead) to sensi-
tivity in the presence of detergent (Fig. 3 B, lane 6), indicates
 
that the 17-kD fragment results from the partial translocation
of ROP2hc into the mitochondrion, or at the very least from
insertion into the mitochondrial outer membrane (MOM). In
contrast, a series of bands concentrated 
 
 
 
25–30 kD remain
resistant to trypsin in all the protease-treated samples (Fig. 3 B,
lanes 4–6). Their persistence in the supernatant fraction (Fig.
Figure 3. Interaction of ROP2hc and its derivatives with mitochondria. (A) The NH2 terminus of ROP2hc contains a putative mitochondrial 
matrix targeting signal, as described in the text. The constructs ROP2hc80 and  98–127ROP2hc extend from aa 80-465 and aa 128–465, re-
spectively, but are identical to ROP2hc in all other respects. All constructs for the expression of ROP2hc and its derivatives possess an engi-
neered initiator methionine (M). The predicted amphipathic helix is underlined and hydroxylated residues marked with an asterisk. (B) 
Translocation of ROP2hc into mitochondria in vitro. Reticulocyte lysate containing 
35S-Met–labeled ROP2hc was incubated with freshly iso-
lated murine liver mitochondria 20 min at 30 C. The reaction was divided into three equal parts that received either no trypsin ( ), trypsin 
( ), or trypsin ( ) in addition to 0.1% Triton X-100 (Tx) on ice for 15 min. Trypsin treatment was stopped by the addition of SBTI, and the re-
actions diluted to 50  l with IB containing SBTI. The mitochondrial pellet (P) and supernatant (S) fractions were obtained after centrifugation 
from all but the Triton X-100–solubilized fraction (Tx). ROP2hc binds to the mitochondrial pellet (lane 2). After the addition of exogenous 
trypsin, a specific trypsin-protected fragment (lane 4, arrowhead) is observed in the pellet fraction. The presence of bands in the 25–30-kD 
range in the trypsin-treated pellet (lane 4), supernatant (lane 5) and the reaction containing both trypsin and TX-100 (lane 6) indicates their pro-
tease resistance is not due to translocation across the MOM. The sequence of ROP2hc protein predicts 50 potential tryptic sites with the longest 
predicted fragment from complete digestion being 4-kD long (unpublished data). The mAb T34A7 recognizes an epitope included in aa 98–
127, at the extreme NH2 terminus of ROP2hc (see text), and immunoprecipitates both full-length ROP2hc (lane 7) and the 17-kD trypsin-pro-
tected fragment from solubilized pellet fractions after import into mitochondria (lane 8, arrowhead). (C) Contribution of the NH2 terminus of 
ROP2hc in translocation into mitochondria in vitro. 
35S-Met–labeled import substrates generated in vitro were incubated with import compe-
tent murine mitochondria as in B. The import of ROP2hc (aa 98–465), ROP2hc80 (aa 80–465), and  98–127ROP2hc was examined, in addi-
tion to the human OTC as a positive control. All the ROP2hc derivatives, including  98–127ROP2hc, bound to the mitochondrial pellet (lanes 
1, 5, and 9). Trypsin treatment of the import reaction resulted (B), in the generation of the 17-kD protease-protected fragment in the ROP2hc 
pellet (lane 3, arrowhead). Protease treatment of the ROP2hc80 import reaction revealed a 19-kD protease-protected fragment associated 
with the mitochondrial pellet after trypsin treatment (lane 7, arrowhead). Deletion of aa 98–127 does not affect binding to mitochondria (lane 
9), but does abolish the generation of a protease-protected fragment (lane 11). This indicates that insertion into and/or translocation across the 
MOM is dependent on the NH2-terminal 30 aa, although other determinants in the protein can mediate binding. The import competence of 
mitochondria was confirmed in all experiments using OTC as a positive control. OTC was efficiently converted from the presequence con-
taining precursor (p) to the mature processed protein (m) as a consequence of translocation to the matrix. Only the processed, mature form of 
the protein (m), is protected from exogenous protease (lane 15). 
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3 B, lane 5) and in the presence of Triton X-100 (Fig. 3 B,
lane 6) indicates that they are inherently protease resistant.
Mitochondrial matrix targeting signals direct transloca-
tion into the matrix in a vectorial fashion led by the NH
 
2
 
terminus (Neupert, 1997). The directionality of ROP2hc
translocation was examined by exploiting the observation
that the epitope recognized by the mAbT34A7 is included
in the putative targeting signal (aa 98–127) (unpublished
data). mAb T34A7 immunoprecipitated full-length ROP2hc
(Fig. 3 B, lane 7), and more significantly the 17-kD pro-
tease-protected fragment (Fig. 3 B, lane 8), from the mito-
chondrial pellet fractions in both the absence of and after
protease treatment.
In all experiments, the import competence of the mito-
chondria was confirmed using human ornithine transcar-
bamylase (OTC) as a control (Horwich et al., 1986). OTC
was correctly imported and processed from the full-length
precursor protein (Fig. 3 C, p, lanes 13 and 14) to the ma-
ture form (Fig. 3 C, m, lanes 13 and 15) as a consequence of
cleavage of the NH
 
2
 
-terminal targeting signal in the matrix
(Horwich et al., 1986).
Because the processing site within ROP2 has not been
precisely mapped and may be somewhat upstream of aa 98
(Fig. 2 A), we examined the interaction of a polypeptide
identical to ROP2hc but originating at aa 80 (ROP2hc80)
(Figs. 2 A and 3 A). Upon interaction with mitochondria,
ROP2hc80 behaved exactly like ROP2hc, binding to the or-
ganelle pellet (Fig. 3 C, lane 5) and revealing a larger (19
kD) protease-resistant fragment (Fig. 3 C, lane 7, arrow-
head) consistent with the increase in molecular weight im-
parted by the 18 aa from aa 80–98 (Fig. 3 A). Because both
ROP2hc and ROP2hc80 include the putative targeting sig-
nal (aa 98–127), we sought to determine its contribution to
translocation across the MOM in vitro.
The role of the putative targeting signal (aa 98–127) in in-
teraction with mitochondria was tested by deleting it to gen-
erate 
 
 
 
98–127ROP2hc. In the in vitro import assay, 
 
 
 
98–
127ROP2hc still bound to mitochondria (Fig. 3 C, lane 9),
but no protected fragment was observed after protease treat-
ment (Fig. 3 C, lane 11). Together, these data indicate that
translocation of the host cytoplasm–exposed domain of
ROP2 into the MOM in vitro is not critically dependent on
the precise processing site, as long as the putative targeting
signal (aa 98–127) is present.
 
ROP2hc does not target the mitochondrial matrix
 
In light of the potential mitochondrial matrix targeting signal
(aa 98–127) in ROP2hc, we examined the effects of treatments
known to block matrix import. We examined the conse-
quences of temperature (0
 
 
 
C), ATP depletion (apyrase), dissi-
pation of the membrane potential across the inner membrane
(carboxyl cyanide 
 
m
 
-chlorophenylhydrazone [CCCP]), and the
requirement for trypsin- sensitive receptors on the mitochon-
drial surface such as TOM20 (reviewed in Neupert, 1997), on
ROP2hc translocation. In addition, the ability of anti-TOM20
antibodies to block import was tested. In control experiments,
the import and processing of the matrix-targeted protein OTC
was blocked at 0
 
 
 
C (Fig. 4 A, OTC, lanes 5–8), and was signif-
icantly inhibited by treatment with apyrase (Fig. 4 A, OTC,
lanes 9–12) or CCCP (Fig. 4 A, OTC, lanes 13–16). As pre-
 
dicted, the mAb T34A7 against aa 98–127 of ROP2hc, did
not affect either the import or processing of OTC (Fig. 4 A,
OTC, lanes 17–20). In contrast, pretreatment of mitochondria
with a chicken anti-TOM20 antibody completely blocked
both the import and processing of OTC (Fig. 4 A, OTC, lanes
21–24), as described previously (Goping et al., 1995).
Surprisingly, the translocation of ROP2hc across the
MOM was only partially inhibited. The 17-kD protease-
protected fragment generated under standard import condi-
tions (30
 
 
 
C) (Fig. 4 A, ROP2hc, lane 3, arrowhead) was
observed at 0
 
 
 
C (Fig. 4 A, ROP2hc, lane 7, arrowhead).
Likewise, apyrase-mediated ATP depletion (Fig. 4 A, ROP2hc,
lane 11, arrowhead) and the dissipation of the 
 
  
 
 by
CCCP (Fig. 4 A, ROP2hc, lane 15, arrowhead) failed to
block the formation of the protease-protected fragment.
In contrast, the importance of the NH
 
2
 
-terminal signal of
ROP2hc (aa 98–127) in translocation is further supported
by the lack of the 17-kD protease-protected fragment when
the monoclonal T34A7 was added (Fig. 4 A, ROP2hc, lane
19, arrowhead). Notably, inhibition by T34A7 was observed
only if the ROP2hc containing reticulocyte lysate was prein-
cubated with the antibody before addition to mitochondria
(unpublished data). In contrast, pretreatment of mitochon-
dria with anti-TOM20 antibodies failed to block the genera-
tion of the protease-protected fragment (Fig. 4 A, ROP2hc,
lane 27). The experiment is presented with an independent
“no treatment” control (Fig. 4 A, ROP2hc, lanes 21–24), as
it was not performed at the time the other treatments were.
 
ROP2hc translocation does not require 
a trypsin-sensitive receptor
 
The role of trypsin-sensitive receptors in addition to
TOM20 on targeting of imported proteins to the matrix
and other mitochondrial compartments is well documented
(Neupert, 1997). As reported previously (Argan et al.,
1983), trypsin pretreatment of mitochondria completely
blocked the import and processing of OTC (Fig. 4 B, lanes
15–18). In contrast, the translocation of ROP2hc across the
MOM of trypsin-pretreated mitochondria was not inhib-
ited, resulting in a slightly smaller (15 kD) protected frag-
ment (Fig. 4 B, lane 8, arrowhead), identical to that ob-
served with nontreated mitochondria (Fig. 4 B, lane 4,
arrowhead). Thus, despite possessing features of a matrix
targeting signal, ROP2hc, in contrast to most imported mi-
tochondrial proteins, translocates across the MOM without
a requirement for a trypsin-sensitive receptor, supporting
the results with the anti-TOM20 antibody (Fig. 4 A)
 
ROP2hc contains both mitochondrial- and
ER-targeting domains
 
Next, we tested the targeting of ROP2hc in vivo. The level
of expression of ROP2hc and ROP2hc80 (unpublished
data) had a significant effect on the localization of the pro-
tein. Relatively low levels of ROP2hc resulted in localization
to rod-shaped and punctate structures reminiscent of mito-
chondria (Fig. 5, A and C, yellow arrowheads). These struc-
tures were confirmed to be mitochondria based on colocal-
ization with the mitochondrial marker cytochrome 
 
c
 
 oxidase
subunit III (COXIII) (Fig. 5, B and C, yellow arrowheads).
Colocalization with mitochondria was confirmed with anti- 
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body to cytochrome 
 
c
 
 oxidase subunit 1 (COXI) (unpub-
lished data), hamster MOM (unpublished data), and the
mitochondrion-specific, membrane potential–sensitive dye
MitoTracker (Molecular Probes) (Fig. 5, E–G).
Increasing ROP2hc accumulation resulted in the signal
“clumping” (Fig. 5 A, bottom cell, D, and E), which was ac-
companied by a loss of the fine rod-shaped structures (Fig. 5
A, top cell, and C). The increasing levels of ROP2hc also
Figure 4. ROP2hc translocation is not 
affected by treatments blocking import 
to the matrix. (A) Effect of treatments 
known to inhibit import to the matrix and 
the mAb T34A7, on ROP2hc, and OTC 
import. The standard import assay, and 
all treatments except for that of tempera-
ture (0 C) were conducted by incubating 
mitochondria with the appropriate 
35S-
Met–labeled substrate in an reticulocyte 
lysate on ice for 15 min, followed by im-
port for 20 min at 30 C. The effect of 
temperature was determined by the 15-
min pretreatment on ice followed by an 
additional 20 min at 0 C. ATP depletion 
was achieved by pretreatment with apy-
rase (5 U/ml) on ice for 15 min followed 
by import for 20 min at 30 C with apy-
rase present. Dissipation of the mem-
brane potential (  ) was achieved by 
pretreatment on ice with CCCP (2 mM), 
followed by import for 20 min at 30 C in 
the presence of CCCP. The effect of the 
mAb T34A7 on import was determined 
by preincubating the reticulocyte lysate 
with the ascites at 1:20 dilution for 15 
min on ice before addition to mitochon-
dria and import at 30 C. Treatment with 
anti-TOM 20 antibody was performed by 
its addition to the import mixture (reticu-
locyte lysate with mitochondria) at 1:10 
dilution for 15 min on ice followed by in-
cubation at 30 C for 20 min. None of the 
treatments blocked the binding of 
ROP2hc to the mitochondrial pellet 
(ROP2hc, lanes 1, 5, 9, 13, 17, 21, and 
25). Insertion and/or translocation across 
the MOM was determined by the genera-
tion of the 17-kD protease-protected 
fragment in the mitochondrial pellet in 
the presence of exogenous trypsin, the 
position of which is shown by the arrow-
head. Neither incubation at 0 C 
(ROP2hc, P, lane 7, arrowhead), ATP de-
pletion (ROP2hc, P, lane 11, arrowhead), 
or the dissipation of the    (ROP2hc, P, 
lane 15, arrowhead), affected the generation of the protease protected fragment indicating ROP2hc does not use the matrix targeted pathway. 
In contrast, preincubation of the reticulocyte lysate with the mAb T34A7 (epitope included in aa 98–127 of ROP2hc) inhibited the generation 
of the ROP2hc protease-protected fragment (ROP2hc, P, lane 19, arrowhead) but failed to inhibit the import and processing of OTC (OTC, lane 
19). Incubation in the presence of anti-TOM20 ablated the import and processing of OTC (OTC, lane 23) but failed to affect ROP2hc transloca-
tion (ROP2hc, lane 23). The “no treatment” control for the anti-TOM20 assay for ROP2hc is in lanes 21–24. As a control for all the treatments 
tested, OTC import and processing from the precursor to the mature (arrowhead) form was blocked by incubation at 0 C (OTC, lane 7), apyrase 
(OTC, lane 11), CCCP (OTC, lane 15), and anti-TOM20 (OTC, lane 23). For OTC, all the treatments (except for T34A7) revealed only the pre-
cursor form (p) when trypsin treatment was excluded (lanes 5 and 6, 9 and 10, 13 and 14, 21 and 22). In this experiment, the inhibition by apy-
rase was incomplete (OTC, lanes 13–16). (B) Pretreatment of mitochondria with trypsin fails to inhibit the translocation of ROP2hc across the 
MOM. The use of PK to assess ROP2hc translocation into mitochondria results in the generation of a slightly smaller (15-kD) protease protected 
fragment in the standard import assay (lane 4, arrowhead). The generation of this fragment is not affected by trypsin pretreatment of mitochon-
dria indicating a trypsin-sensitive surface receptor is not involved in ROP2hc translocation (lane 8, arrowhead). Trypsin pretreatment com-
pletely abolished the import and processing of OTC as only the precursor form is observed in the absence of PK (lanes 15 and 16). Upon the 
addition of PK to nontrypsinized mitochondria, only the mature (m) form is detected in the pellet (lane 13). The band in the supernatant fraction 
represents contamination from the pellet as it is comprised entirely of the processed, mature (m) form (lane 14). The effect of trypsin pretreat-
ment was examined by treating mitochondria with trypsin (1 mg/ml final concentration) for 15 min on ice, inactivation with SBTI as above, and 
reisolation by centrifugation. Pelleted mitochondria were resuspended in import buffer   SBTI to 20 mg/ml organelle protein and a standard 
import reaction performed. Import was assessed using protection from proteinase K as described in the experimental procedures. 
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correlated with the labeling of nonmitochondrial sites (Fig.
5, A and B, bottom cell, D, red arrowhead, and E–G, green
arrowhead). In addition, a subset of mitochondria failed to
colocalize with ROP2hc (Fig. 5, E–G, red arrowheads).
We sought to determine whether the nonmitochondrial
localization of ROP2hc corresponded to ER. ROP2hc (Fig.
5 H) exhibited some colocalization with the ER marker cal-
nexin (Fig. 5 I). These appear as a yellow signal concentrated
in the perinuclear area of the transfected cell in the merged
image (Fig. 5 J). The red signal in the merged image (Fig. 5
J) likely corresponds to mitochondria. This observation sug-
gests that ROP2hc localizes to both mitochondria and ER
after expression in vivo.
Next, we examined whether deletion of the NH
 
2
 
-terminal
30 aa required for in vitro mitochondrial import played a role
in ROP2hc localization in vivo. After expression of a 
 
 
 
98–
127ROP2hcGFP chimera, a distinct pattern of localization
was observed. Unlike ROP2hc, 
 
 
 
98–127ROP2hcGFP (Fig.
6, A, C, D, and F, green arrowheads) did not target signifi-
cantly to mitochondria, as detected with either MitoTracker
(Fig. 6, B and C, red arrowhead) or anti-COXI antibody
(Fig. 6, E and F, red arrowheads). Some colocalizing was ob-
served (Fig. 6, D–F, bottom cell, yellow arrowhead) and is
likely due to the limitations in the resolving power of confo-
cal microscopy. Such patches of apparent colocalization were
only found where a high concentration of both signals was
present (Fig. 6, D and E). Notably, expression of 
 
 
 
98–
127ROP2hcGFP did not lead to the clumping and other
changes in organelle organization (Fig. 6, B, C, E, and F) ob-
served with ROP2hc (Fig. 5, B, C, E, and F).
The pattern of 
 
 
 
98–127ROP2hcGFP localization sug-
gested it may be directed to the ER (Fig. 6 G). This was con-
firmed using an antibody against the KDEL ER retrieval
motif (Fig. 6 H), which colocalized extensively with the chi-
meric deletion construct (Fig. 6 I). Together, these data in-
dicate that ROP2hc contains an ER localization motif(s) in
aa 98–465. They also suggests that aa 98–127 of ROP2hc
are critical for mitochondrial targeting and the associated
changes in mitochondrial organization.
The contribution of the 30-aa putative mitochondrial tar-
geting signal (aa 98–127) to the in vivo targeting was exam-
ined directly using the GFP chimera aa 98–127GFP chimera.
With relatively low levels of expression, the aa 98–
127GFP construct (Fig. 7 A, yellow arrowhead) localized
primarily to mitochondria visualized using an anti-COXI
antibody (Fig. 7 B, yellow arrowhead). This is best visualized
as yellow staining in the merged image (Fig. 7 C, yellow ar-
rowhead). Like ROP2hc (Fig. 5, A, D, and G), increased ac-
Figure 5. ROP2hc localizes to both mitochondria 
and ER upon transient expression in CHO cells. Ex-
pression of ROP2hc results in the protein targeting to 
mitochondrial as well as nonmitochondrial locations. 
Colocalization of ROP2hc (A and E) with mitochon-
dria (visualized using an anti-COXII antibody [B] or 
MitoTracker [F]) is detected as a yellow signal in the 
merged image (C, D, and G, yellow arrowhead). 
ROP2hc targeting to nonmitochondrial sites is de-
tected as either a red (A and D, red arrowhead) or 
green (D and G, green arrowhead) in the merged im-
age (D and G). Nonmitochondrial targeting of 
ROP2hc was particularly apparent with high levels of 
expression that resulted in the clumping of the 
ROP2hc signal (A, compare top and bottom cells). The 
possibility that the nonmitochondrial localization of 
ROP2hc corresponded to ER was examined using 
T34A7 (H) and anticalnexin (I) antibodies. The merged 
image reveals perinuclear colocalization (J, yellow 
signal in the merged image) with distinct non-ER la-
beling (J, red signal in the merged image). This signal 
likely represents mitochondria. Note the clumping of 
the ROP2hc signal in (H). Bars, 15  m. 
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cumulation of aa 98–127GFP exhibited, in addition to colo-
calization with mitochondria (Fig. 7, D–F, yellow arrowhead),
evidence of clumping (Fig. 7 D) and localization to nonmi-
tochondrial sites (Fig. 7, D–F, green arrowhead). In addi-
tion, a subpopulation of mitochondria did not label with aa
98–127GFP (Fig. 7, D–F, red arrowhead).
The possibility that aa 98–127GFP contain an ER-targeting
motif was examined by counterstaining with an anti-KDEL
antibody. The staining for aa 98–127GFP (Fig. 7, G–I, green
arrowhead) was generally distinct from that for the ER (Fig. 7,
G–I, red arrowhead). Some incidental colocalization (Fig. 7,
G–I, yellow arrowhead) was observed, and is likely due to the
limitations of the resolution of the microscope. Taken to-
gether, aa 98–127 of ROP2hc are sufficient for mitochondrial
targeting, but appear to lack any ER targeting domains.
Characterization of ROP2hc binding 
to organelle membranes
Next, we compared the binding of the ROP2 derivatives
tested in vivo, to purified organelles in vitro. Mitochondria
and ER-enriched microsomes were prepared from murine liv-
ers (see Materials and methods). By immunoblot, the mito-
chondrial proteins COXI and COXIII were detected exclu-
sively in the mitochondrial preparations (Fig. 8 A). Both
anti-KDEL and anticalnexin antibodies strongly recognized
the ER preparation (Fig. 8 A). Although no KDEL signal was vis-
ible in the mitochondrial preparation, a trace calnexin signal
was apparent (Fig. 8 A), likely due to the mitochondrion-
associated ER or mitochondrion-associated membrane (MAM)
fraction, which is highly enriched in liver (Vance, 1990).
The binding of ROP2hc,  98–127ROP2hcGFP, aa 98–
127GFP, and GFP to the organelles was examined. In addi-
tion, the nature of binding to organelle membranes was as-
sessed by determining its resistance to extraction with 0.1 M
Na2CO3, pH 11.5. As reported previously (Fujuki et al.,
1982), carbonate treatment caused the efficient extraction of
proteins (soluble and peripherally membrane associated)
from both mitochondria and ER (unpublished data). After
this treatment, integral membrane proteins like COXIII
(mitochondria) and calnexin (ER) fractionated exclusively in
the pellet fractions (unpublished data).
All constructs, with the exception of GFP (Fig. 8 B,
bottom panel), exhibited binding to mitochondria (Fig.
8 B, top three panels, carbonate). ROP2hc and  98–
127ROP2hcGFP were found almost exclusively in the mito-
chondrial pellet fraction (Fig. 8 B, top two panels, carbon-
ate). Extraction with carbonate had no significant effect on
ROP2hc binding, but did cause the displacement of some
 98–127ROP2hcGFP into the supernatant fraction (Fig. 8
B, top two panels, carbonate). These data suggest that de-
spite the apparent absence of a predicted transmembrane do-
main, these proteins behave like integral membrane proteins
in association with mitochondria. In contrast,  50% of
Figure 6. Localization of  98–
127ROP2hcGFP after transient transfec-
tion of CHO cells. After expression in 
CHO cells,  98–127ROP2hcGFP exhib-
ited a predominantly juxta- or perinu-
clear staining pattern (A, D, and G) that 
radiated in a reticulated pattern (most ev-
ident in D and G). This pattern (A and D, 
green arrowhead) was largely distinct in 
its distribution from mitochondria (red ar-
rowhead, visualized with anticytochrome 
c [B] and MitoTracker [E]). This results in 
a merged image with clearly defined ar-
eas of  98–127ROP2hcGFP localization 
(C and F, green arrowheads) and those of 
mitochondria (C and F, red arrowheads). 
Some coincidental colocalization of the 
signals was detected in areas where both 
ROP2hc and mitochondria were abun-
dant (F, yellow arrowhead) and are likely 
due to the limits of resolution of the con-
focal microscope. The possibility that 
 98–127ROP2hcGFP (G, detected using 
anti-GFP) was localizing to ER was exam-
ined using an anti-KDEL antibody (H). 
The merged image revealed near perfect 
concordance of the two signals (I, yel-
low, indicating  98–127ROP2hcGFP 
targets the ER). Bars, 15  m.T. gondii PVM–organelle association | Sinai and Joiner 103
aa 98–127GFP bound to mitochondria (Fig. 8 B, third
panel, carbonate  ). Paradoxically, treatment with carbonate
caused the fractionation of all of this construct into the pel-
let fraction (Fig. 8 B, third panel, carbonate  ).
The binding of ROP2hc and  98–127ROP2hcGFP to
ER-enriched microsomes was tested. ROP2hc bound ER
less efficiently than mitochondria, and while a portion was
resistant to carbonate extraction, a significant pool remained
in the supernatant fraction (Fig. 8 B, top panel, carbonate
 ). In contrast,  98–127ROP2hcGFP, which targeted ex-
clusively to ER (Fig. 6), exhibited efficient binding to ER in
vitro that was completely resistant to extraction with carbon-
ate (Fig. 8 B, second panel, carbonate  ). The aa 98–
127GFP construct, containing the putative mitochondrial
targeting domain of ROP2hc, exhibited very limited bind-
ing to ER (Fig. 8 B, third panel, carbonate  ). As was ob-
served with the binding of this protein to mitochondria,
carbonate treatment caused aa 98–127GFP to localize ex-
clusively to the pellet fraction (Fig. 8 B, third panel, car-
bonate  ). Given the highly basic nature of the aa 98–127
sequence, precipitation in the presence of carbonate (pH
11.5) cannot be ruled out.
In light of the highly basic pI of ROP2hc (predicted pI
11.2) (Beckers et al., 1994), we were concerned that it too
might pellet, albeit differentially, with mitochondria and ER
compared with aa 98–127GFP, after carbonate extraction as
a result of its being precipitated. We tested this possibility
using sucrose floatation gradients, in which precipitated
ROP2hc should remain at the load fraction (Fig. 8 C, frac-
tions 1 and 2), whereas membrane-associated ROP2hc
should float to its equilibrium density. ROP2hc bound and
floated to the appropriate equilibrium with both mitochon-
dria (Fig. 8 C, Mito, NT) and ER (Fig. 8 C, ER, NT) co-
fractionating with the organelles as determined by Coomassie
blue staining of the gels (unpublished data). Carbonate ex-
traction failed to strip the protein from either mitochondria
(Fig. 8 C, second panel, carbo) or ER (Fig. 8 C, bottom
panel, carbo). These results indicate that full-length ROP2hc
interacts with both mitochondria and ER with the charac-
teristics of an integral membrane protein.
Given the high-affinity interaction of ROP2hc (Fig. 8, B
and C) in vitro and the efficient trafficking of  98–
127ROP2hcGFP to ER in vivo, we examined whether these
proteins could be imported cotranslationally into canine mi-
crosomes. Cotranslational import into the ER, based on pro-
tease protection, was not observed with either ROP2hc or
 98–127ROP2hc under conditions where Escherichia coli
 -lactamase (BLA) was efficiently imported, processed, and
protected from exogenous protease (Fig. 8 D). Rather, com-
bined with the results in Fig. 8, B and C, this suggests that
Figure 7. Localization of aa 98–
127GFP after transient transfection into 
CHO cells. After expression in CHO 
cells, aa 98–127GFP localized primarily 
to rod-shaped and punctate structures (A, 
yellow arrowhead) that colocalized to a 
significant extent with mitochondria dec-
orated with an antibody against COXI (B, 
yellow arrowhead). The merged image 
indicates a high degree of colocalization 
(C, yellow arrowhead) in the transfected 
cell. Increasing levels of expression result 
in the accumulation of aa 98–127GFP on 
distended and clumped structures (D and 
F, yellow arrowhead) revealed to be mi-
tochondria using MitoTracker (E and F, 
yellow arrowhead) and COXI (unpub-
lished data). In addition, regions of aa 
98–127GFP not colocalizing with mito-
chondria (D and F, green arrowhead) as 
well as mitochondria not colocalizing 
with aa 98-127GFP (E and F, red arrow-
head) are apparent. Localization of aa 
98–127GFP (G) to the ER was examined 
using anti-KDEL (H). Limited colocaliza-
tion was only observed in areas with a 
high concentration of both signals (G–I, 
yellow arrowhead). However, most of 
the signal failed to colocalize with aa 
98–127GFP (G–I, green arrowhead) and 
ER (G–I, red arrowhead) being found in 
distinct regions of the cell. Bars, 15  m.104 The Journal of Cell Biology | Volume 154, 2001
Figure 8. Interaction of ROP2hc and its derivatives with murine liver mitochondria and ER. (A) Mitochondria and ER-enriched microsomes 
were prepared as described in Materials and methods. After the loading of 100  g total protein, the mitochondrial proteins COXI and COXIII 
were detected exclusively in the mitochondrial but not on the ER preparation. The ER was detected using anti-KDEL and anti-calnexin anti-
bodies. Both antibodies illuminated their targets in the ER prep. Although no KDEL signal was visible in the mitochondrial prep, a trace cal-
nexin signal was apparent. This is likely due to the mitochondrion-associated ER or MAM fraction, which is highly enriched in liver (Vance, 
1990). (B) The binding of ROP2hc,  98–127ROP2hcGFP, aa 98–127GFP, and GFP to mitochondria and ER was determined without further 
treatment and after extraction with 0.1 M Na2CO3, pH11.5 (Carbonate  ), as indicated. Equivalent volumes of the organelle pellets (P) and 
supernatants (S) were resolved by SDS-PAGE and exposed by fluorography. Both ROP2hc and its derivatives bind efficiently to both mito-
chondria and ER. ROP2hc binding to mitochondria is resistant to extraction with carbonate (top panel). In contrast, binding to ER is not as 
strong and exhibits both extractable- and carbonate-resistant binding (top panel). Deletion of the proposed 30-aa NH2-terminal mitochondrial 
targeting signal ( 98–127ROP2hcGFP) does not significantly affect binding to either mitochondria or ER (second panel). Furthermore,  98–
127ROP2hcGFP is partially extracted from mitochondria by carbonate treatment, but is completely resistant to extraction from ER (second 
panel). The 30-aa NH2-terminal signal promotes the binding of the passenger protein GFP to mitochondria but not ER (third panel). Carbonate 
treatment promotes the fractionation of aa 98–127GFP into the pellet fraction with both organelles (third panel). This suggests the protein may 
be precipitated due to its basic nature by the carbonate treatment. Finally, the soluble passenger protein GFP exhibits no binding to either mi-
tochondria or ER under any conditions (bottom panel). (C) Based on sucrose floatation gradients, the apparent membrane association of 
ROP2hc to mitochondria and ER is not due to neither the precipitation or aggregation of the protein. ROP2hc bound to organelle membranes 
in the absence (NT, no treatment) and after carbonate extraction (Carbo) was incorporated into 55% sucrose and a continuous sucrose gradi-
ent (55–20%) established as described in the Materials and methods. In the absence of carbonate extraction (Mito-NT, ER-NT), the majority of 
the signal in all cases floated into the gradient, coinciding with the distribution of the organelles based on Coomassie blue staining of the gels 
(unpublished data) indicating true membrane association. After carbonate extraction (Mito-Carbo, ER-Carbo) ROP2hc continues to float into 
the gradient, indicating its association with organelle membranes in maintained and resistant to extraction with carbonate. Had the protein 
been extracted or merely precipitated, a significant signal would be observed in fractions 1 and 2 (load fractions). This indicates ROP2hc 
interacts with both mitochondria and ER with high affinity behaving like an integral membrane protein. (D) Neither ROP2hc nor  98–
127ROP2hc are cotranslationally imported into canine microsomes. Cotranslational import of ROP2hc,  98–127ROP2hc, and E. coli BLA 
was performed as described in the Materials and methods. Although both ROP2hc (lane 1) and  98–127ROP2hc (lane 4) were synthesized, 
they were not translocated either partially or completely into the ER lumen and remain protease sensitive (PK, lanes 2 and 5). In contrast, BLA 
was efficiently imported into the microsomes and processed from the precursor (p, lane 7) to the mature form (m, lanes 7 and 8). Only the 
mature form is protease protected (PK, lane 8) and the protection is sensitive to detergent treatment (PK, Tx, lane 9), indicating the mi-
crosomes are import competent.T. gondii PVM–organelle association | Sinai and Joiner 105
ROP2hc and  98–127ROP2hc form high-affinity interac-
tions with the ER membrane.
Discussion
In this study we show that the rhoptry-derived protein
ROP2, the founding member of a family of rhoptry proteins
exposed to the host cell cytosol (Beckers et al., 1994), medi-
ates PVM–organelle association. This is achieved by the host
cytoplasm–exposed domain, ROP2hc, inserting into or-
ganelle membranes and establishing a stable association. De-
spite possessing an NH2-terminal signal (Fig. 3 A; Beckers et
al., 1994) with features on a matrix targeting signal (Neu-
pert, 1997), ROP2hc insertion and translocation into the
MOM (Fig. 3) does not occur by the conventional import
pathway (Fig. 4). By what alternative mechanism is ROP2hc
translocated across the MOM? ROP2hc import, presumably
exposing its NH2 terminus to the intermembrane space
(IMS), has features reminiscent of apocytochrome c import
(Stuart and Neupert, 1990; Jordi et al., 1992; Dumont,
1996). ROP2hc shares some potentially important physical
features with the IMS-localized cytochrome c and its recep-
tor cytochrome c heme lyase (CCHL) (Lill et al., 1992).
Like cytochrome c (Stuart and Neupert, 1990; Dumont,
1996; Wang et al., 1996) and CCHL (Lill et al., 1992),
ROP2hc (aa 98–465) is a highly basic (predicted pI 11.2)
and unusually proline-rich (8.2%) protein (Beckers et al.,
1994). These properties are believed to be important in the
translocation of both cytochrome c (Stuart and Neupert,
1990; Dumont, 1996) and CCHL (Lill et al., 1992).
Alternatively, ROP2hc could be using the low-efficiency by-
pass pathway (Pfaller et al., 1989) or a receptor analogous to
the yeast TOM5 receptor. Both pathways are resistant to
trypsin, with the TOM5 pathway capable of directing the
translocation of the small Tim proteins (Tim 8, 9, 10, 12, and
13) into the IMS via the general insertion pore (Kurz et al.,
1999). However, unlike the bypass pathway (Pfaller et al.,
1989), import by the small Tim pathway occurs at 0 C and re-
quires neither exogenous ATP nor the    (Kurz et al., 1999).
Another class of proteins translocates across the plasma
membrane into the cytoplasm of mammalian cells by a
poorly understood mechanism involving the direct penetra-
tion through the lipid bilayer (reviewed in Schwarze and
Dowdy, 2000). These proteins, containing protein transloca-
tion domains (PTD), include the HIV transactivator Tat
(Frankel and Pabo, 1988), herpes simplex virus VP22 (Elliott
and O’Hare, 1997), and the Drosophila melanogaster protein
Antennapedia (Thoren et al., 2000). Although the mecha-
nism is unclear (Schwarze and Dowdy, 2000), these mole-
cules are highly basic, with a high concentration of arginine
and/or twin arginine motifs implicated in diverse evolution-
arily distant protein transduction pathways (Robinson, 2000;
Schwarze and Dowdy, 2000). These features are all found in
both ROP2hc, the NH2-terminal signal (aa 98–127) (Fig. 3
A) required for mitochondrial targeting and import (Figs. 3
C and 7), and the remainder of the molecule ( 98–
127ROP2hc; aa 98–465) that binds both mitochondrial and
ER membranes (Fig. 8, B and C). Nonetheless, several im-
portant differences between the PTD-containing proteins
and ROP2hc must be noted. First, unlike the PTD proteins
that completely translocate across the bilayer (Schwarze and
Dowdy, 2000), ROP2hc appears to insert into it without
complete translocation (Figs. 3, 4, and 8). Secondly, while
the translocation of PTD-containing proteins has not been
examined in organelles, domains of ROP2hc exhibit distinct
properties with regard to mitochondria and ER interaction
(Fig. 8), suggesting that ROP2 may interact with specific
protein or lipid domains in the target membranes.
The lack of complete translocation of ROP2hc, which
does not encode obvious stop transfer sequences (von
Heijne, 1990) into mitochondria in vitro, is best explained
by the presence of a tightly folded domain in the protein.
Folded protein domains block translocation across the
MOM (Eilers and Schatz, 1986; Rassow et al., 1989, 1990).
The presence of a folded domain in ROP2hc is inferred by
the series of protease-resistant bands between 25 and 30 kD,
after digestion of ROP2hc with either trypsin or proteinase
K (Figs. 3 and 4). Notably, the presence of a translocation-
incompetent subdomain within ROP2hc mimics the situa-
tion in vivo, where the ROP2 protein is embedded in the T.
gondii PVM, making its complete translocation impossible.
The mechanism underlying the resistance of ROP2hc to
carbonate extraction from either mitochondria or ER re-
mains enigmatic. The protein lacks a stretch of noncharged
and/or hydrophobic aa in the host cytoplasm exposed do-
main (aa 98–465; Fig. 2 A) that are long enough to span a
lipid bilayer (Beckers et al., 1994). The most likely mecha-
nism involves direct insertion into the lipid bilayer, which
may explain its interaction with both mitochondria and ER.
Lipid and/or protein properties of these membranes also
likely contribute to the differences in both the affinity of
binding and the ability to translocate across the membrane
(Figs. 3 and 8). ROP2hc inserts into the MOM (Figs. 3 and
4), integrating into it (Fig. 8, B and C). With ER mem-
branes, high-affinity association (Fig. 8, B and C) is estab-
lished without apparent translocation (Fig. 8 D). Whether
the lack of microsomal import is merely a result of the
in vitro conditions as has been suggested previously for
TOM20 mutants (Kanaji et al., 2000) remains unclear.
ROP2 is the founding member of a family of highly re-
lated proteins found exclusively in T. gondii (Beckers et al.,
1994, 1996; Sadak et al., 1988) that are likely to be essen-
tial. The likely essentiality and the presence of multiple iso-
forms (Beckers et al., 1994, 1996), complicates a gene
knockout strategy to directly test the role ROP2 in PVM–
organelle association. Furthermore, blockade of association
after microinjection of anti-ROP2 antibodies is complicated
by the existence of multiple targeting signals. Our previous
data suggested that the extent of organelle association was
governed by the concentration of organelles in the vicinity
of the vacuole, and little else (Sinai et al., 1997).
The data establish a potential mechanistic paradigm by
which a protein anchored in one organelle may “capture”
another by inserting into its membrane, despite the apparent
presence of a transmembrane domain. Such interactions,
morphologically similar to PVM–organelle association, have
been identified between mitochondria and other organelles,
most notably the ER (reviewed in Bereiter-Hahn, 1990),
and include the specialized MAM fraction of the ER (Trot-
ter and Voelker, 1994; Vance and Shiao, 1996).106 The Journal of Cell Biology | Volume 154, 2001
MAM-mediated ER–mitochondrial association and the
lipid trafficking, which is facilitated (Trotter and Voelker,
1994; Vance and Shiao, 1996), provides a potential para-
digm for the role of PVM–organelle association in T. gondii
biology. We have suggested that sites of PVM-associated or-
ganelles may be contact points for the bulk transfer of lipids
in a manner analogous to MAM-mediated phospholipid
transfer between mitochondria and ER (Sinai and Joiner,
1997; Sinai et al., 1997). Of note, preliminary experiments
suggest that T. gondii is unable to synthesize phosphatidyl-
choline de novo (unpublished data), implying that parasite
requirements for phosphatidylcholine and other lipids may
be satisfied by scavenging from host cell sources.
In conclusion, the elucidation of a mechanism for PVM–
organelle association highlights the importance of studying
the cell biology of pathogen–host interactions. These studies
reveal aspects of mammalian cell biology that would other-
wise not be readily apparent. With millennia of coevolution
behind them, intracellular pathogens have mastered cell bio-
logical principles that they are now revealing to us.
Materials and methods
Reagents
Buffers used include: PBS (137 mM NaCl, 2.7 mM KCl, 10 mM NaH2PO4,
and 1.8 mM KH2PO4 adjusted to pH 7.4), PBS
2  (PBS supplemented with 1
mM each of CaCl2 and MgCl2), Hepes mannitol sucrose buffer (220 mM
D-mannitol, 70 mM sucrose, 2 mM Hepes, pH 7.4), import buffer (IB) (Hepes
mannitol sucrose buffer   10 mM methionine), cell disruption buffer (Sinai
et al., 1997), immunoprecipitation buffer (IP) (PBS or IB [as indicated be-
low] with 0.2% Triton X-100), and immunoprecipitation wash (IPW) (IP
with 300 mM NaCl). Proteases used include: trypsin (10 mg/ml stock in
IB), and proteinase K (PK) (3.2 mg/ml in IB; Boehringer). Protease inhibitors
used include: soybean trypsin inhibitor (SBTI) (100 mg/ml stock in IB),
PMSF (10 mM stock in isopropanol), and leupeptin (5 mM stock in DMSO;
Boehringer). Modulators of import used include: CCCP and potato apyrase
(EC 3.6.1.5). Detergents used include: Digitonin (Calbiochem), Triton
X-100, and SDS. Other reagents include Duracryl (high tensile strength
acrylamide; Genomic Solutions), paraformaldehyde (3% in PBS
2 ), goat
serum (GIBCO BRL), and BSA. Unless specified, all reagents were pur-
chased from Sigma-Aldrich.
Cell culture and parasite infection
T. gondii strain RH, CHO-K1 (ATCC-CCL163), and primary human fore-
skin fibroblasts were maintained as described previously (Sinai et al.,
1997). The kinetics of PVM–mitochondrial association immediately after
T. gondii infection were performed using human foreskin fibroblast cells
preloaded with MitoTracker on coverslips in a 24-well dish placed in a
37 C water bath (Sinai et al., 1997). Cells were infected with T. gondii at a
multiplicity of infection of 50. Parasite interaction with the cells was
stopped at 1, 5, and 10 min postinfection by aspirating unbound organ-
isms, washing once with PBS, and fixation in 3% paraformaldehyde. Cov-
erslips were prepared for immunofluorescence using an anti-GRA3 anti-
body as described below.
Plasmid construction and PCR
Plasmid constructs used for in vitro expression were generated in pET17b
(Novagen). The vectors used for in vivo expression of ROP2hc and GFP
chimeras were pCR3.1(Invitrogen) and pWay2.1-Srf (Lo et al., 1998) (pro-
vided by Dr. Thom Hughes, Yale University College of Medicine, New Ha-
ven, CT), respectively. All inserts were generated using the PCR with either
Taq (Perkin Elmer) or Vent polymerase (New England Biolabs, Inc.) ac-
cording to the manufacturers recommendations, using pCBROP2.4 (1–5
ng) (Beckers et al., 1994) as a template. The sequences (5 –3 ) of the for-
ward (F) and reverse (R) PCR primers for ROP2hc cloned into pET17b were
(F-ggaattccatattgagccacacagagactccgacaca, R-cgggtacctcagtggtggtggtggtg-
gtgctggcggtagggggagc), and (F-aaaggtaccatgagccacacagagaccccgacacag,
R-tttgaattcctacgttgggtggtgctggcggta) for pCR3.1 and pWay2.1-Srf. Inserts
for ROP2hc80 and  98–127ROP2hc subcloned into pET17b used the
same reverse primer as ROP2hc, and the forward primers (aaaggtacc-
cat0atgggaggctcatggctggag) and (ggaattccatatgtcagatggcggaggagaaccaccg-
cag), respectively. The inserts into pWay2.1-Srf generating the GFP chimeras
aa 98–127GFP and  98-127ROP2hcGFP were amplified using (F-aaagg-
taccatgagccacacagagaccccgacacag, R-ataatacccgggtggtgcctggcggtaggggag)
and (F-aaaggtaccatgtcagatggcgcaggagaaccaccg, R-tttgaattcctacgttgggtggt-
gctggcggta), respectively. Reverse primers used for ROP2hc and deriva-
tives in pET17b contain a sequence encoding 4His codons after two His
codons at aa 462 and 463 of ROP2 (Beckers et al., 1994). All primers were
synthesized at the W.M. Keck Center (Howard Hughes Medical Institute,
Yale University, New Haven, CT). Constructs cloned into pET17b, pCR3.1,
and pWay2.1-Srf were ligated into NdeI-EcoRI–, KpnI-EcoRI–, and KpnI-
SmaI–restricted gel-purified vectors, respectively, using sites engineered at
the termini of the amplification primers. The presence of a T7 polymerase
promoter in pCR3.1 and pWay2.1-Srf allows for in vitro protein synthesis.
In vitro expression of BAP-ROP2TM/CT was achieved by subcloning that
chimera from a pNTP/s derivative (Hoppe et al., 2000) into pCR3.1. Unless
indicated, all enzymes for molecular biological application were pur-
chased from New England Biolabs, Inc.
In vitro protein synthesis
35S-Met–labeled substrates for mitochondrial import assays were synthesized
using a coupled rabbit reticulocyte lysate transcription/translation system
(TNT; Promega), using 2  g DNA per reaction. All constructs except that for
human ornithine transcarbamylase (phOTC) (Horwich et al., 1984) were
transcribed using the T7 polymerase (Promega). The OTC gene was tran-
scribed using SP6 polymerase (Horwich et al., 1984) (Ambion or Promega).
Determination of ROP2 topology in the PVM
5  l of in vitro–synthesized 
35S-Met–labeled ROP2hc and BAP-ROP2TM/
CT were immunoprecipitated in 200  l IP using either 5  l of anti-R/DG
(see below) or 2  l antibacterial alkaline phosphatase (anti-BAP) (3 –5 )
along with 30  l of 10% protein A–Sepharose (Pharmacia) for 4 h on a ro-
tating wheel at 4 C. Protein A–Sepharose beads were harvested by centrif-
ugation and washed thrice with IPW. The washed beads were boiled in
SDS-PAGE sample buffer and eluted proteins resolved by SDS-PAGE, pre-
pared for fluorography, and visualized as below.
Mitochondrial import assays
Mitochondria used in import assays were isolated from murine livers as de-
scribed previously (Conboy and Rosenberg, 1981) and used immediately in
import reactions. A standard protease protection assay was performed by
incubating 8  l of mitochondria (20 mg/ml in IB) with 12  l of TNT reac-
tion product for 20 min at 30 C. The reaction was split into three equal ali-
quots. The aliquots were treated with 0.6  l of SBTI or PMSF (for trypsin or
PK, respectively), 0.6  l 10  protease (trypsin, 10 mg/ml or PK, 3.2 mg/ml)
in IB, or 0.6  l 10  protease   0.6  l 1% Triton X-100 in IB. Protease
treatments used either trypsin (15 min at 4 C) or PK (30 min at 0 C). Reac-
tions were stopped by adding either SBTI (10 mg/ml) or PMSF (1 mM final
concentration) to all samples and incubating for 5 min at 4 or 0 C for
trypsin- and PK-treated samples, respectively. Reactions were fractionated
by centrifugation and prepared for SDS-PAGE as described in the figure
legends. SDS-PAGE (Laemmli, 1970) was performed using either 13 (Fig. 3)
or 15% (Fig. 4) Duracryl gels. Gels were prepared for fluorography using
Autofluor (National Diagnostics) as recommended by the manufacturer,
vacuum dried, and visualized using Kodak Biomax MR or AR x-ray film. To
determine whether the NH2-terminal domain of ROP2hc and ROP2hc80
was protease protected, the mitochondrial pellet fraction from an import
assay as above (both untreated and trypsin treated) was solubilized in 300
 l IP (IB   SBTI (10 mg/ml) and leupeptin (5  M). The lysate was incu-
bated with 5  l of ascites fluid containing the mAb T34A7 and 15  l of
protein G–Sepharose (10% slurry in PBS) (Amersham Pharmacia Biotech).
Immunoprecipitations were carried out essentially as described above.
Microsome import assays
Cotranslational import into canine microsomes was performed essentially
as described by Hegde et al. (1998). E. coli BLA synthesized off an SP6 pro-
moter was used as a positive control as described previously (Hegde et al.,
1998). Both the canine microsomes and the pBLA construct were gifts from
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Binding and fractionation assays
Murine liver mitochondria (Conboy and Rosenberg, 1981) and ER (Paulik
et al., 1988) were prepared as described previously and frozen at  80 C
until use. The purity of the preparations was assessed using immunoblot
analysis with organelle-specific markers (COXI and COXIII) for mitochon-
dria (1:1,000]), calnexin (1:500), and anti-KDEL (1:1,000 for ER). Immuno-
blots were performed as previously described (Sinai et al., 1997).
Labeled ROP2hc,  98–127ROP2hcGFP, aa 98–127GFP, and GFP were
synthesized in vitro, added in duplicate tubes to either purified mitochon-
dria or ER (100  g total protein), and brought to 100  l with Tris-buffered
isosmotic sucrose, pH 7.4. Binding was allowed to proceed in ice water
for 30 min. Carbonate treatment was performed by the addition of 100  l
of 0.2 M sodium carbonate, pH 11.5 for 30 min. The untreated controls re-
ceived an equal volume of isosmotic sucrose. After incubation, the sam-
ples were centrifuged for 15 min in an air-driven ultracentrifuge (Airfuge;
Beckman Coulter) set at 30 psi. Both the organelle pellets and the superna-
tants were recovered and resolved by SDS-PAGE.
To confirm the membrane association of ROP2hc, sucrose floatation
gradients were performed. Samples prepared as above were incorporated
into 1.5 ml of 60% sucrose in 10 mM Tris-Cl, pH 7.4, and gradients estab-
lished as described previously (Sinai et al., 1997). In light of dilution with
the sample, the sucrose concentration in the load fraction was  55%. The
gradients were centrifuged and harvested as described previously (Sinai et
al., 1997). 150  l from each fraction was mixed with 4  SDS-PAGE sam-
ple buffer, and boiled and resolved on a 10% Duracryl gel. The gels were
stained by Coomassie blue to identify the organelle-positive fractions,
treated with a fluorophore (Amplify; National Diagnostics), and exposed
for fluorography as above to identify ROP2hc-positive fractions.
Antibodies
Antibodies used in this study for immunofluorescence microscopy and/or
immunoblot analysis include mAbs T34A7 and T3H11 against ROP2,3,4
(Sadak et al., 1988) and GRA3 (Bermudes et al., 1994), respectively, anti-
mammalian COXI (Molecular Probes), anti-cytochrome c (Zymed Labora-
tories), and anti-KDEL (StressGen Biotechnologies). In addition, rabbit sera
against GFP (CLONTECH Laboratories, Inc.), mammalian COXIII (pro-
vided by Dr. Pietro De Camilli, Yale University School of Medicine) (Ne-
moto and De Camilli, 1999), calnexin (Hebert et al., 1995), E. coli alkaline
phosphatase (BAP) (3 –5 ), and the R/DG fraction of T. gondii (Beckers et
al., 1994) were used. Finally, a chicken anti-TOM20 IgY was provided by
Drs. Ing Swie Goping and Gordon Sinore (McGill University, Montreal,
Canada) (Goping et al., 1995).
Transfection
CHO cells, at 80% confluence in a six-well plate (Falcon), were transfected
using the QIAGEN Superfect reagent as recommended by the manufac-
turer. Cells were incubated with the transfection mix for 3 h at 37 C,
washed once with PBS, trypsinized, and plated onto eight coverslips, each
placed in a 24-well culture dish. The transfected gene product was detected
by immunofluorescence analysis between 18 and 24 h posttransfection.
Fluorescence Microscopy
Transiently transfected cells were seeded on coverslips and immunofluo-
rescence was performed as described previously (Sinai et al., 2000). All
antibodies were diluted in 20% goat serum as follows: mouse mono-
clonals T34A7 and T3H11 at 1:300, anti-COXI, anti-cytochrome c at
1:600, anti-KDEL at 1:200, and rabbit anti-GFP, anti-COXIII, and anti-cal-
nexin at 1:500. Immunofluorescence on MitoTracker-labeled cells (de-
scribed in Sinai et al., 1997) was performed using either T34A7 or anti-
GFP incubation for at least 1 h at room temperature. Double labeling
(T34A7 with anti-COXIII or anti-calnexin, anti-GFP with anti-COXI or anti-
cytochrome c, or anti-KDEL) was performed simultaneously for at least 1 h
at room temperature. Species-specific secondary antibodies conjugated to
either FITC (Calbiochem), Oregon green (Molecular Probes) or Texas red
(Molecular Probes) were used as indicated in the figure legends.
Laser scanning confocal microscopy was performed at the Electron Mi-
croscopy and Imaging Suite at the University of Kentucky College of Medi-
cine using a Leica TCS True Confocal microscope system. All images were
acquired using a 100X/1.4 NA Plan Apo oil immersion objective. Digitized
images were imported into Adobe Photoshop, and all adjustments for
brightness and contrast applied uniformly to the entire field.
Electron Microscopy
Electron microscopy on CHO cells infected with T. gondii for 20 h was
performed as described previously (Sinai et al., 1997).
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